Research News and Research

RSS

First Edition: February 18, 2010

Today's headlines focus on continuing hopes for health reform as well as various health industry developments.

18 Feb 2010

INC Research creates management program for strategic clinical delivery alliances with pharma and biotechnology customers

INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.

18 Feb 2010

NPG becomes official media partner to the 2010 WIN Symposium

Nature Publishing Group (NPG) is the official media partner to the 2010 WIN (Worldwide Innovative Networking) Symposium, it was announced today. The second annual WIN Symposium, which will be held in the Palais des Congrès, Paris, 7–9 July 2010, will bring together hundreds of oncology researchers from around the world to discuss how best to tailor therapies for patients with cancer.

18 Feb 2010

Single microRNA exhibits potential to forecast outcomes of MPM

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announced today that the results of a joint study with the NYU Langone Medical Center were published online on February 16th, 2010, and are set to be published in the March 1st issue of the American Association for Cancer Research’s journal, Cancer Research.

18 Feb 2010

Spectranetics fourth-quarter revenues rise up 11%

Spectranetics Corporation today reported financial results for the quarter and full year ended December 31, 2009.

18 Feb 2010

BPA has no effects on brain development: New study

This new study, which exposed pregnant rodents to a range of BPA dietary doses from low to high, concluded that BPA had no effects on brain development or behavior in their offspring that had been exposed to BPA in utero and throughout development. The robust study was conducted by highly qualified researchers at WIL Research Laboratories.

18 Feb 2010

Vertebroplasty effective in treatment of VCFs

The results of a study of more than 4500 patients from six Italian EVEREST (European Vertebroplasty Research Team) Centers (Dr. G.C. Anselmetti-Candiolo Torino, Dr. G. Bonaldi-Bergamo, Dr. P. Carpeggiani-Pisa, Dr. S. Masala-Roma, Dr. M. Muto-Napoli,) confirms the effectiveness of vertebroplasty in treating vertebral compression fractures (VCFs), finding that the procedure provides significant and sustained pain relief.

18 Feb 2010

UCSF receives $1.15M grant to integrate family planning into HIV treatment and care

UCSF has received a $1.15 million grant from the Bill & Melinda Gates Foundation to determine if integrating family planning into HIV treatment and care will increase contraceptive use and decrease unintended pregnancy among HIV-positive women. UCSF will partner with the Kenya Medical Research Institute and Ibis Reproductive Health to conduct the research.

18 Feb 2010

V-Day to host three benefit productions of The Vagina Monologues as part of global violence against women

Ottawa V-Day, part of a global campaign to end violence against women and girls, will host three benefit productions of The Vagina Monologues on Friday, February 26 and Saturday, February 27 at the National Gallery of Canada.

18 Feb 2010

URAC to conduct workshop highlighting multiple aspects of medication adherence

URAC, the nation's leading health care accreditation and education organization, will conduct a workshop on "Medication Adherence and Medication Possession Ratio as a Critical Metric" at the 15th Annual Pharmacy Benefit Management Institute (PBMI) Conference in Phoenix, Ariz.

18 Feb 2010

Combination therapy that delays nursing home admission for AD earns 43% patient share in U.S. and 30% in Europe

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe Alzheimer's disease, a combination therapy that delays nursing home admission at 19 months would earn 43 percent patient share, according to surveyed U.S. neurologists. In comparison, in Europe, such an agent would earn a slightly lower patient share of 30 percent, according to surveyed European neurologists. This lower share estimate is possibly a result of higher price sensitivity of European markets.

18 Feb 2010

Easier walking for amputees: Artificial foot that recycles energy

An artificial foot that recycles energy otherwise wasted in between steps could make it easier for amputees to walk, its developers say.

18 Feb 2010

Training birth attendants in essential newborn-care techniques can reduce perinatal deaths

New findings in a study led by the director of the University of Alabama at Birmingham (UAB) Division of Neonatology show that that training birth attendants in essential newborn-care techniques reduced stillbirths by more than 30 percent - and potentially could save as many as 1 million lives worldwide each year.

18 Feb 2010

State-of-the-art review of stereological methods for lung morphometry

The ATS and the European Respiratory Society have issued official standards for the quantitative assessment of lung structure.

18 Feb 2010

Training in newborn care and resuscitation to birth attendants increases likelihood of baby's survival

In developing countries, where millions of babies die in the womb or soon after birth, research has shown that providing training in newborn care and resuscitation to birth attendants significantly increases the likelihood of a baby's survival.

18 Feb 2010

AdvanSource Biomaterials reports 2.9% decrease in third-quarter revenue

AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2010 third quarter ended December 31, 2009.

18 Feb 2010

Pfizer Canada accepts entries for seventh round of competition for Pfizer CVRAP

Pfizer Canada is currently accepting entries for its seventh round of competition for the Pfizer Cardiovascular Research Awards program (CVRAP). The program, first launched in October 2005, was developed to fund and support independent cardiovascular research in Canada.

18 Feb 2010

Signaling protein has key role in fighting bacterial infection and inflammation in intestinal tract: Study

A signaling protein that is key in orchestrating the body's overall immune response has an important localized role in fighting bacterial infection and inflammation in the intestinal tract, according to a study by UC San Diego School of Medicine investigators, published in the journal Cell Host and Microbe.

18 Feb 2010

RiskMetrics questions Novartis merger proposal

The Alcon Independent Director Committee (the “Committee”) of Alcon, Inc. today announced that RiskMetrics Group, Inc., a global leader in risk management, corporate governance and financial research and analysis, has raised concerns about the adequacy of the merger proposal by Novartis AG (“Novartis”) to Alcon’s minority shareholders and the legality of any attempt by Novartis to unilaterally impose a full takeover of Alcon.

18 Feb 2010

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet “Quad” regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).

18 Feb 2010

Research News and Research

First Edition: February 18, 2010

INC Research creates management program for strategic clinical delivery alliances with pharma and biotechnology customers

NPG becomes official media partner to the 2010 WIN Symposium

Single microRNA exhibits potential to forecast outcomes of MPM

Spectranetics fourth-quarter revenues rise up 11%

BPA has no effects on brain development: New study

Vertebroplasty effective in treatment of VCFs

UCSF receives $1.15M grant to integrate family planning into HIV treatment and care

V-Day to host three benefit productions of The Vagina Monologues as part of global violence against women

URAC to conduct workshop highlighting multiple aspects of medication adherence

Combination therapy that delays nursing home admission for AD earns 43% patient share in U.S. and 30% in Europe

Easier walking for amputees: Artificial foot that recycles energy

Training birth attendants in essential newborn-care techniques can reduce perinatal deaths

State-of-the-art review of stereological methods for lung morphometry

Training in newborn care and resuscitation to birth attendants increases likelihood of baby's survival

AdvanSource Biomaterials reports 2.9% decrease in third-quarter revenue

Pfizer Canada accepts entries for seventh round of competition for Pfizer CVRAP

Signaling protein has key role in fighting bacterial infection and inflammation in intestinal tract: Study

RiskMetrics questions Novartis merger proposal

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring